Hi Friends,
We are still waiting for David to be admitted to the hospital. He will be treated on the hematology floor of the U of A hospital, so we have to wait for a bed to open up (someone is discharged, or otherwise). It is hard to wait because, even though the prognosis statistics are good, they are good for folks who are treated. They are not good for people who are not. Yesterday we followed up with his doctor and the clinic to ensure that we've not been missed/didn't miss an update.
When we followed up, we did get some news. They have been working through the genetic sequencing of David's leukemia and uncovered that he has a specific CEBPA mutation. In leukemia there are more positive mutations than others (just like the X-men, some are Eye-Scream, some are Jean Grey) and we are relieved to hear that the doctor was quite pleased that it was a CEBPA mutation. Some facts about the CEBPA mutation:
- 70% of patients go into complete remission (not just remission after the induction phase of chemo - which we had the 80% remission rate before)
- Patients with a CEBPA mutation are very responsive to consolidation treatment (which is the second, out-patient, chemotherapy that comes after the initial chemotherapy) which puts patients into remission
- CEBPA is a relatively rare mutation, about 5% of the population here
- Often patients with the CEBPA mutation do not need a stem cell transplant to go into remission (which soothes the concerns around stem cell transplants as they come with their own bucket of risks and challenges)
- there may be a familial element for CEBPA, so we are going to ask the doctor about that (for our children's knowledge)
- A bed opens up for David soon (and ideally not requiring someone's passing for it to open up)
- His bloodwork stays stable
- The CEBPA mutation does not have a familial impact
1 comment:
I approve use of the Oxford comma in the title xo
Post a Comment